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Abstract 
Objectives: To estimate out-of-pocket (OOP) expenditure due to hospitalization from NCDs and its 
impact on households in India.  
Methods: The study analysed nationwide representative data collected by the National Sample Sur-
vey Organization in 2014 that reported health service utilization and health care related OOP expen-
diture by income quintiles and by type of health facility (public or private). The recall period for inpa-
tient hospitalization expenditure was 365 days. Consumption expenditure was collected for a recall 
period of one month. OOP expenditure amounting to >10% of annual consumption expenditure was 
termed as catastrophic. Weighted analysis was performed. 
Results: The median expenditure per episode of hospitalisation due to NCDs was USD 149 – this was 
~3 times higher among the richest quintile compared to poorest quintile. There was a significantly 
higher prevalence of catastrophic expenditure among the poorest quintile, more so for cancers 
(85%), psychiatric and neurological disorders (63%) and injuries (63%). Mean private sector OOP 
hospitalization expenditure was nearly five times higher than in the public sector. Medicines ac-
counted for 40% and 27% of public and private sector OOP hospitalization expenditure respectively.  
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Conclusion: Strengthening of public health facilities is required at community level for the preven-
tion, control and management of NCDs. Promotion of generic medicines, better availability of essen-
tial drugs and possible subsidization for the poorest quintile will be measures to consider to reduce 
OOP expenditure in public sector facilities.   
 
Keywords: non communicable diseases; injury; cancer; out of pocket expenditure; catastrophic ex-
penditure 
 
Introduction 
Noncommunicable Diseases (NCDs) are a major threat to general health, productivity, development 
and economic growth and account for 63% of annual global deaths.(1) Most of these deaths are 
premature and preventable. The probability of dying during the most productive years (ages 30-70) 
from one of the four main NCDs [cancer, cardiovascular disease, diabetes mellitus and stroke] is 
26%. If urgent action is not taken, NCDs could hurt economic growth and cause an estimated eco-
nomic loss of $47 trillion during the period 2010-30. (2)  
In an ageing nation like India, an increase in the prevalence of NCDs is likely to put additional 
burdens on households and the resource-constrained healthcare delivery system. India runs the risk 
of losing about $4.6 trillion by 2030 due to NCDs and mental health conditions. In 2010, NCDs ac-
counted for more disability-adjusted life years (DALYs) in India than communicable diseases.(2) 
With a rising burden of NCDs, delivering healthcare in developing countries has many chal-
lenges. Even when such care is available, individuals with NCDs will continue to face significant risks 
of hospitalization and the associated burden of high costs of financing care. A review of the litera-
ture shows that households spend a substantial share of their income on health care leading to 
catastrophic expenditure and impoverishment. (3) Each year, globally, approximately 150 million 
people in 44 million households face catastrophic expenditure and about 100 million people in 25 
million households are pushed into poverty because they have to pay for health care.(3) 
The extent of the financial burden due to NCDs in India is poorly researched.(4,5) A gap area is 
the household impact of out-of-pocket (OOP) hospitalization expenditure due to NCDs. This informa-
tion would be helpful in formulating social protection strategies to increase financial risk protection 
for households affected with NCDs. With the rising burden of NCDs, we need to look for answers 
whether people have access to the services they need to prevent or control these diseases, and the 
extent to which they suffer financial catastrophe or impoverishment in accessing the services. 
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There have been a few studies in India analysing household expenditure on chronic illnesses ei-
ther combined or separately for diabetes, CVD and injuries.(6–11) However, these studies were lim-
ited to a specific geographical area or a hospital with unrepresentative samples. Another study by 
Engelgau et al. explored OOP for NCD care and the risk of catastrophic payment in a nationally rep-
resentative survey sample (12) more than a decade ago. Since then there has been an unprece-
dented rise in the burden of NCDs.(13) The public health infrastructure in India has seen massive 
growth after significant investments through the National Health Mission since 2005.(14) The private 
sector has also proliferated due to government apathy.(15) In the present scenario, we have limited 
estimates of household expenditure patterns on hospitalization due to NCDs, both in public and the 
private sector. Availability of National Sample Survey Organisation (NSSO) data, from a nationally 
representative survey conducted in 2014, provided us an opportunity to study this.  
Therefore, the present study was thus undertaken to estimate the proportion of all hospitaliza-
tions in public sector facilities due to non-communicable diseases by income quintiles, and the me-
dian out-of-pocket expenditure and prevalence of catastrophic expenditure due to hospitalization 
from non-communicable disease by type of health facility and income quintiles. 
 
Methods 
This is a secondary data analysis of a nationwide survey data collected by the NSSO, India. The data 
source is the representative nationwide survey collected by the National Sample Survey Organization 
(NSSO) in its 71st round (2014) on ‘Health’ and ‘Education’. NSSO is a national organisation under the 
Ministry of Statistics, established in 1950 to regularly conduct surveys and provide useful statistics 
on socio- economic status of households, demography, health, industries, agriculture, consumer ex-
penditure etc. Results of NSSO surveys are published in the form of NSS reports available at the 
website of the Ministry (www.mospi.nic.in). So far there have been 71 rounds of surveys, the last 
(71st round) was carried out for six months from January  to June 2014. A stratified multi-stage sam-
pling design was adopted. The first stage units were the census villages in the rural sector and Urban 
Frame Survey (UFS) blocks in the urban sector. The ultimate stage units were households in both 
sectors. 4577 villages and 3,720 urban blocks were surveyed, from which 36,480 and 29,452 house-
holds were sampled in rural and urban areas respectively. 333,104 persons from 65,932 households 
were interviewed. Detailed methods can be found in the survey report.(16)  
OOP expenditure for each episode of hospitalization was recorded. Detailed expenditure was 
available for drugs; diagnostic tests (including ECG, X-ray, pathological tests, etc.); professional fees 
for doctors; payments to hospital/institution; other medical expenses (physiotherapy, personal 
medical appliances, blood, oxygen, attendant charges etc.); and other indirect costs. Indirect costs 
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included transport for patients and other accompanying persons, food related expenses, lodging 
charges and others. Household consumption expenditure was recorded as well as other socio-
demographic characteristics including caste, occupation, gender and education. Data were also col-
lected on type of facility (public or private) accessed for medical care.  
The recall period was 365 days for assessing inpatient hospitalization expenditure, and 1 month 
for household consumption expenditure. OOP expenditure per hospitalization episode amounting to 
more than 10% of annual consumption expenditure was termed as ‘catastrophic’. (17,18)  
Disease conditions in the household survey were self-reported. We matched the categories in 
the surveys to broad ICD-10 disease classifications to distinguish between major NCD categories and 
communicable diseases (Box 1).   
 
Data analysis 
Data were imported into SPSS version 17.0 for analysis. The unit of analysis was an episode of hospi-
talization. The study population was divided into quintile groups based on monthly per capita con-
sumption expenditure (MPCE). The household monthly per capita consumption expenditure limits 
(in USD) for the five quintiles are as follows: first quintile (2-16), second quintile (17-22), third quin-
tile (23-30), fourth quintile (31-46) and the fifth quintile (47-538). Median values/percentages for all 
indicators were compared across each of the five MPCE quintiles and type of health facility (public 
and private). Median hospitalization expenditure per episode was estimated for those who reported 
hospitalization due to NCD. The Kruskal-Wallis test was used to evaluate the statistical significance of 
differences in expenditures between the quintiles. Chi-square test for trend was used to test linear 
trends across quintiles. Since it was a multistage stratified random survey, estimates were derived by 
applying sampling weights given by the NSSO.  
 
Ethical approval 
The Ethics Advisory Group of International Union Against Tuberculosis and Lung Disease, Paris, 
France, determined that ethics clearance was not required for this study. 
 
Results 
Of a total of 57,456 hospitalizations, 25% were due to NCDs, 22% to communicable diseases and 
53% to other conditions. 11,843 subjects reported 14,609 episodes of hospitalizations due to non-
communicable disease in the last 365 days, of which 1.6% of episodes were removed due to missing 
data. Among the cases of hospitalization due to NCDs 31% were due to injuries; 25% to CVD; 18% to 
psychiatric/neurological conditions; 9% to respiratory diseases; 8% to endocrine/metabolic disorders 
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and 8% to cancers. 85% of respondents reported one episode of hospitalization in the previous year; 
11% reported two episodes and 4% reported more than 2 episodes. 26% were females. The mean 
age of the respondents was 49 years (sd=16). The mean duration of hospitalization was highest in 
cases of cancer (15 days), followed by injuries and psychiatric/neurological disorders (9 days), endo-
crine/metabolic diseases (8 days), CVD and respiratory diseases (7 days).  
 
Hospitalisation-related expenditure due to NCDs  
Median expenditure per episode of hospitalisation due to NCDs was 149 USD. The expenditure in-
curred was ~3 times higher among the richest quintile than in the poorest quintile. There was a sig-
nificantly higher prevalence of catastrophic expenditure among the poorest quintile, more pro-
nounced with cancers (85%), psychiatric and neurological disorders (63%) and injuries (63%) (Table 
1). Public sector utilization by the poorest quintile was twice as common as by the richest quintile 
(Table 2). 
Median private sector OOP hospitalization expenditure was nearly 3-5 times higher than the 
public sector due to various NCDs. Private sector hospitalization expenditure was more than five 
times compared to public sector hospitalization expenses in case of cardiovascular diseases and inju-
ries. Medicines accounted for 40% of public and 27% of private sector OOP hospitalization expendi-
ture. In 26% of hospitalizations expenditures were sourced through borrowing or sale of assets – this 
was significantly higher among the poorest quintile (33%) than the richest (19%), more common 
when care was sought in the private sector (29%) than in the public sector (22%) and common in 
case of cancer. Indirect costs were more than two times higher in the public sector (24%) than in the 
private sector (10%) (Table 3). Nearly 4.4% of respondents were insured. Among the insured, median 
hospitalization expenditure was significantly higher (USD 519) compared to the non-insured (USD 
160). 
 
NCD related hospitalization leading to catastrophic household expenditure  
Hospitalization due to an NCD had a 3 times higher odds of incurring catastrophic spending than 
hospitalization due to a communicable disease. For cancer, the impact was greatest with the odds of 
catastrophic expenditures being 12 times higher than for hospital stays due to a communicable dis-
ease (Table 4). 
Discussion 
The study shows that NCD-related expenditure per episode of hospitalisation in India is high and 
catastrophic in among the poorest quintile. Cancers, psychiatric and neurological disorders and inju-
ries were the most expensive. Expenditure was higher when care was accessed in the private sector.  
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The utilization of public facilities showed a pro-poor distribution, which is corroborated by 
Shankar et al who also reported higher public sector utilization by the poor in three states of North 
India.(18) This is an encouraging sign considering the rising burden of NCDs. It lends support to the 
view that strengthening of the public health system is instrumental in providing care for the rising 
epidemic of NCDs.(19) However the results of the study also showed that private care is very costly, 
which might be the reason why poor people make greater use of public care facilities. The propor-
tion of hospital stays due to NCDs in the public sector has remained stagnant at around 41% since 
2004.(12) However, use of public services has decreased sharply with the increase in wealth quintile 
class. Thus people who are poor are heavily reliant on public health facilities and are therefore most 
affected by the unavailability of quality services in the public sector. 
About half of the patients belonging to the lowest two quintiles approach the private sector for 
hospitalization due to NCDs. It is possible that patients with NCDs consider their illness as serious re-
quiring better services. So despite their poor economic status, they might prefer costlier private 
care. Also, there is a general scepticism about quality of public health services.(20,21) The full survey 
report states the following reasons for not availing government services: poor quality of care, long 
waiting times, services not available or the facility too far. Thus, the public sector needs to be 
strengthened in terms of quality of care, infrastructure and availability of services, providers and 
drugs in order to increase its access and utilization. With higher health spending under the National 
Rural Health Mission we may be on track. 
 
Medicines accounted for 40% of public sector OOP hospitalization expenditure which is signifi-
cantly higher than in the private sector (27%). This supports a large body of evidence showing that 
medicines form a large component of the health care out-of-pocket expenditure.(6,22,23) This find-
ing is to be interpreted with caution and does not mean that medicines are more expensive in the 
public than in the private sector. Rather, it means that as a percentage of total expenses, medicines 
contribute the most in public sector, while the absolute costs remain lower than in the private sec-
tor. The lower percentage of medicine costs in the private sector is due to higher costs of other ser-
vices (like diagnostic tests, procedures and room rent) which are free or subsidised in the public sec-
tor. Poor availability of essential medicines for chronic diseases in public health facilities forces pa-
tients to purchase medicines from the private sector.(24) Thus, to increase access and affordability 
of health care, promotion of generic medicines and improved availability of medicines and subsidiza-
tion of the poorest population quintiles in the public sector are required.(25) The Rajasthan model of 
a free drug scheme has increased access to health care for the underserved, reduced in OOP and re-
sulted in savings to the government.(26) A drug pricing policy is needed to improve the availability of 
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affordable generics in the public sector, either by better targeting of existing public spending for 
medicines or by increasing the public budget on essential medicines.  
Cardiovascular disease is the largest cause of mortality and accounted for more than one-fourth 
of all deaths in India in 2008.(27) Our study reveals prohibitive costs of care due to CVD in the pri-
vate sector, with one-fifth of hospitalizations paid for by borrowings or sale of personal assets and 
medicines. The private sector is also typically driven by use of advanced medical technology, thus in-
creasing the costs of diagnosis, care and treatment. We speculate that there may be unnecessary (ir-
rational) overuse of such technology for increasing hospital activity and profit margins by the private 
health sector. This merits specific investigation. The issue of affordability is further magnified by the 
low penetration of health insurance in India. There is no coverage for preventive check-ups, diagno-
sis or any medical care. Along with poor awareness, this is a huge barrier towards lowering the bur-
den of CVDs through preventive measures. 
Nearly 40% of those insured were prevented from incurring catastrophic expenditure due to in-
surance payments. There is a need to mitigate this catastrophic expenditure through prepayment 
risk pooling mechanisms, such as social health insurance and tax-based financing of health care. In 
practice it has been found that the beneficiaries of such programmes are often not actually poor. 
Thus packages should be redesigned to target the poor and the disadvantaged. This study shows 
that even after six years of implementation of Rashtriya Swasthya Bima Yojana, a government social 
health insurance scheme, there is a high prevalence of catastrophic expenditure due to hospitaliza-
tion for NCDs in public sector facilities among the poorest quintiles. Considering the long term 
chronic care and repeated hospitalizations for NCDs, separate customized insurance packages 
should be designed for patients with this group of morbidities. However, the median hospitalization 
expenditure among the insured was more than three times higher than among the non-insured, 
which reflects moral hazards of insurance requiring preventive mechanisms.   
Hospitalizations due to injuries lead to a high prevalence of catastrophic OOP expenditure. 
There was also a higher prevalence of OOP hospitalization expenditures being paid for by borrow-
ing/debt/sale of assets in both the public and private sectors. Other studies have also outlined the 
high burden of OOP health care expenditure associated with injuries in India.(28,29)  
Apart from cancer, injury care leads to higher OOP and impoverishment of households. Similarly 
other studies have also reported higher OOP for injuries compared with other diseases and ailments. 
(30) This might be due to the fact that injuries requiring hospitalizations are usually severe and lead 
to more fatalities and disabilities.(30) Furthermore, the impact of injuries is sudden and rapid requir-
ing immediate hospitalization, which demands sophisticated emergency trauma care services and 
prolonged duration of hospital stay. A review of economic evidence in LMICs suggests that the direct 
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median medical cost of injury was US$291 which increased 14-fold i.e. US$4085 when studies in-
cluded direct medical, direct non-medical and indirect costs.(31) This clearly shows the devastating 
financial impact of injury on households. There is therefore a need for advocacy for effective finan-
cial protection mechanisms in India against high OOP expenditure through insurance and universal 
health care. Various cost-effective injury prevention strategies are established which include strict 
legislative measures to regulate vehicle safety and road safety, installation of speed bumps, motor-
cycle helmet and seat belt legislation, breath testing campaigns and drowning prevention pro-
grammes. Thus, in view of the high burden of injuries, high cost of injury care and availability of cost 
effective preventive interventions there is significant potential for huge cost savings 
through implementation of established preventive strategies.(31)  
There is high OOP hospitalization expenditure related to cancer care. The prevalence of catas-
trophic expenditure is highest in those with cancers in all the quintiles, but especially amongst the 
poorest. Cancer treatment in private hospitals is expensive in India as evident from other 
studies.(32) The high OOP expenditure due to cancer is sourced from borrowing/sale of assets in 
more than one third of patients.(32) The cost of cancer care is prohibitive due to costly medicines, 
sophisticated equipment and modern technology. Cancer also requires prolonged period of hospi-
talization as evident in this study. Providing cancer care free of cost at all public health facilities 
would put an enormous financial burden on the health system, but targeting the poorest quintile 
seems feasible and equitable. Some state level initiatives, such as the Yashashwini health insurance 
scheme in Karnataka and similar schemes in Andhra Pradesh and Tamil Nadu, cover cancer treat-
ment for people living below the poverty line.(32)  
Current programmes that address cancer prevention, care and treatment have not been effec-
tive due to limited scale of implementation. It is imperative to strengthen cancer control activities at 
the community with strong prevention messages, early screening and proper management as most 
of the common cancers are preventable.(33)  
Our data confirm the important role that the private sector currently plays in the provision of 
health services for hospitalizations associated with NCDs. However the median OOP hospitalization 
expenditure in the rivate sector was 3-5 times higher than in the public sector. In the last decade 
there has been a significant increase in private sector expenditure on healthcare. During 2004-14, 
the out-of-pocket expenditure for inpatient care per episode in the public sector diminished, 
whereas it grew by 3.6% per year in private sector.(34) This is a reflection of the inability of the gov-
ernment to regulate the private sector. The govern-ment needs to regulate the private sector and at 
the same time use the private infrastructure to provide comprehensive preventive, promotive and 
curative care services for NCDs that are accessible and affordable.    
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 Given that people living with NCDs face high risks of catastrophic health expenditure due to the 
long-term nature of their illness and OOP payments, the health system must provide universal ac-
cess to quality health care, reduce health inequities and improve financial risk protection through 
universal health care (UHC). Many countries have already introduced NCD packages into UHC pro-
grams using frameworks developed by WHO.(35) Thus, NCD prevention and control should be priori-
tized in UHC design and implementation.  
There are some limitations in this study. Firstly, consumption expenditure in the survey does not 
differentiate between food and non-food expenditure. WHO recommends a 40% cut-off level for 
non-food expenditure.(36) In this study we have used a threshold of 10% of annual consumption ex-
penditure. However, this does not provide an accurate estimate of catastrophic expenditure since 
the expenditure on food as a proportion of total consumption expenditure is higher for poorer 
households. Hence the results of the present study for catastrophic expenditure may be an underes-
timate for the poorer income quintiles and overestimate for higher income quintiles. Secondly, con-
sumption expenditure as an alternative to income also might overestimate the findings. Thirdly, indi-
rect costs do not include wage losses due to the illness, which might underestimate the impact of 
health care expenditure on the household. Lastly, the data used for the analyses are self-reported 
and may be subject to recall and other biases. 
 
Conclusion 
The study shows that a household with a member suffering from any NCD is exposed to significant 
financial risks which lead to catastrophic household expenditure. This trend is likely to worsen over 
time due to the rising NCD epidemic and the ageing population. We strongly advocates for publicly 
funded risk protection mechanisms targeting the poor. The use of NCD health services from public 
facilities results in lower out of pocket household expenses than the use of private services, which 
warrants strengthening of public sector health facilities for better financial risk protection. Promo-
tion of generic medicines and better availability and access to essential drugs will significantly reduce 
OOP expenditure in public sector facilities. NCD prevention and control should be prioritized in uni-
versal health care design and implementation.  
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Box 1. Classification of 2014 household survey response categories from National Sample Survey 
Data into disease categories 
 
Communicable diseases 
Fever with rash/ eruptive lesions, loss of consciousness 
Fever due to malaria, typhoid, Diphtheria, Whooping Cough, fevers of 
unknown origin) 
Tuberculosis, Filariasis  
Tetanus  
HIV/AIDS and other Sexually Transmitted Diseases  
Jaundice  
Diarrhoea/ dysentery/ increased frequency of stools 
with or without blood and mucus in stools 
Worms infestation 
Skin infection (boil, abscess, itching) and other skin diseases 
Acute upper respiratory infections 
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Non-communicable diseases 
Cancers 
Psychiatric and Neurological disorders 
Endocrine, nutritional and metabolic disorders 
Cardiovascular disorders 
Chronic respiratory conditions (Bronchial asthma) 
Injuries 
 
Other conditions 
Blood disorders 
Disorders of the gastrointestinal system 
Disorders of the genitourinary system 
Obstetric complications 
Disorders of eye and ear 
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Table 1. Out-of-pocket hospitalization expenditure per episode of hospitalization due to Non-Communicable Diseases by income quintiles in India, 2014^ 
 
Income 
quintiles 
Cancer Endocrine 
/metabolic 
Psychiatric 
/neurological 
Cardiovascular Chronic res-
piratory 
Injuries Total 
Median hospitalization expenditure in USD for each episode (IQR) 
1st MPCE quin-
tile 
400(96-957) 88(25-191) 108(37-226) 67(24-218) 79(31-138) 105(38-268) 93(34-231) 
2nd MPCE quin-
tile 
310(111-465) 142(55-235) 102(45-274) 122(37-314) 68(32-154) 111(45-317) 114(45-305) 
3rd MPCE quin-
tile 
277(140-826) 98(47-200) 148(57-295) 123(52-276) 83(33-185) 139(42-354) 137(47-309) 
4th MPCE quin-
tile 
383(117-769) 132(43-300) 205(75-527) 177(66-457) 114(48-240) 213(70-579) 185(67-499) 
5th MPCE quin-
tile 608(282-1360) 215(78-400) 347(117-943) 291(86-1320) 
197(102-
431) 
 331(108-885) 298(102-873) 
Overall 
357(143-864) 130(53-272) 152(58-398) 148(54-412) 101(42-200) 156(50-447) 149(55-406) 
Out-of-pocket hospitalization expenditure as a proportion of annual household consumption expenditure expressed in median per-
centage (%) 
1st MPCE quintile 56 14 14 12 13 16 15 
2nd MPCE quintile 25 11 10 12 7 11 11 
3rd MPCE quintile 23 7 12 09 6 09 10 
4th MPCE quintile 26 7 9 08 7 13 09 
5th MPCE quintile 22 8 12 09 6 09 09 
Overall 25 8 12 10 8 11 11 
p-value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Proportion of hospitalization episodes leading to catastrophic expenditure (%) 
1st MPCE quintile 85 63 63 55 55 63 61 
2nd MPCE quintile 73 50 49 55 45 52 52 
3rd MPCE quintile 75 39 57 48 33 45 48 
4th MPCE quintile 75 41 48 42 31 55 48 
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I 
 
 
 
 
^ weighted 
analysis; 
IQR=Interquartile Range; MPCE=monthly per capita expenditure; *>10% of annual household consumption expenditure; The household monthly per capita 
consumption expenditure limits (in USD) for the five quintiles are as follows: first quintile (2-16), second quintile (17-22), third quintile (23-30), fourth quin-
tile (31-46) and the fifth quintile (47-538) 
 
Table 2. Utilization of public sector facilities for hospitalization due to non-communicable diseases by income quintiles in India, 2014^ 
 
 
 
 
 
 
 
 
 
 
 
 
^ weighted analysis; MPCE=monthly per capita expenditure; numbers given indicate percentage utilizing public sector facility for hospitalization due to non-
communicable disease; The household monthly per capita consumption expenditure limits (in USD) for the five quintiles are as follows: first quintile (2-16), 
second quintile (17-22), third quintile (23-30), fourth quintile (31-46) and the fifth quintile (47-538) 
 
5th MPCE quintile 74 30 56 49 28 47 48 
Overall 76 44 55 49 40 53 52 
p-value 0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Proportion of hospitalization episodes whose expenditure was sourced from borrowings/sale of physical assets (%) 
1st MPCE quintile 38 27 39 28 22 37 33 
2nd MPCE quintile 48 27 31 30 25 33 32 
3rd MPCE quintile 36 23 29 20 18 26 25 
4th MPCE quintile 26 16 33 26 19 19 24 
5th MPCE quintile 28 21 19 19 10 19 19 
Overall 36 22 30 24 19 27 26 
p-value <0.001 0.002 <0.001 <0.001 <0.001 <0.001 <0.001 
Income quintiles Cancer Endocrine 
/metabolic 
Psychiatric 
/neurological 
Cardiovascular Chronic res-
piratory 
Injuries Total 
1st MPCE quintile 52 54 54 56 63 57 56 
2nd MPCE quintile 46 42 48 45 61 46 47 
3rd MPCE quintile 39 36 36 36 41 44 39 
4th MPCE quintile 41 35 36 34 39 28 33 
5th MPCE quintile 28 18 22 20 26 29 23 
Overall 39 35 39 37 47 42 40 
p-value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
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Table 3. Out-of-pocket hospitalization expenditure characteristics for each episode of hospitalization due to non-communicable disease in public and pri-
vate sector in India, 2014^ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Level of care Cancer Endocrine 
/metabolic 
Psychiatric 
/neurological 
Cardiovascular Chronic respi-
ratory 
Injuries Total 
Median hospitalization expenditure (IQR) 
Public sector 169(62-495) 46(20-95) 59(26-138) 45(17-113) 48(15-95) 55(21-137) 55(21-138) 
Private sector 548(277-1161) 191(100-364) 245(122-537) 241(107-615) 163(85-343) 290(127-695) 254(116-600) 
Overall 357(143-864) 130(53-272) 152(58-398) 148(54-412) 101(42-200) 156(50-447) 149(55-406) 
Proportion of hospitalization episodes sourced from borrowings/sale of personal physical assets (%)  
Public sector 30 17 28 18 17 24 22 
Private sector 40 25 31 27 20 30 29 
Overall 36 22 30 24 19 28 26 
p-value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Medicine cost as a percentage of total hospitalization expenditure a (%) 
Public sector 32 40 43 43 36 36 40 
Private sector 24 28 30 27 29 26 27 
Overall 27 31 33 29 31 28 30 
p-value 0.01 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Indirect cost as a percentage of total hospitalization expenditure b (%) 
Public sector 17 25 18 21 24 25 24 
Private sector 8 10 11 11 12 10 10 
Overall  10 12 13 13 15 13 13 
p-value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Diagnostic cost as a percentage of total hospitalization expenditure c (%) 
Public sector 17 16 18 17 11 12 15 
Private sector 09 10 12 12 11 09 11 
Overall 10 11 13 13 11 10 12 
p-value <0.001 <0.001 <0.001 0.001 0.2 0.003 0.001 
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^ weighted analysis; Cost estimates are given in terms of US Dollars; Indirect cost includes transport for patient and others, expenses on food, escort, lodg-
ing charges and others etc; IQR stands for Inter quartile range; a proportion of per episode hospital expenditure spent towards medicine expressed in me-
dian percentage; b proportion of per episode hospital expenditure spent towards indirect costs expressed in median percentage; c proportion of per episode 
hospital expenditure spent towards diagnostic tests expressed in median percentage 
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Table 4. Adjusted odds ratios for catastrophic spending for patients with specific Non-Communicable 
Diseases compared to those with  
Communicable Diseases, India, 2014^ 
 
Type of disease Type of expenditure Unadjusted 
OR (95% CI) 
Adjusted OR 
(95% CI) Catastrophic¥  
N (%) 
Non catastro-
phic  
N (%) 
Cancer 807(74) 286(26) 7.2**(6.2-
8.2) 
12.2**(12.0-
12.4) 
Endocrine/metabolic disor-
ders 
512(42) 700(58) 1.9**(1.6-
2.1) 
2.0**(1.9-2.1) 
Psychiatric and neurological 
disorders 
1410(54) 1212(46) 2.9**(2.7-
3.2) 
3.5**(3.2-3.8) 
Cardiovascular diseases 1904(53) 1720(47) 2.8**(2.6-
3.0) 
2.8**(2.6-3.0) 
Respiratory diseases 469(37) 795(63) 1.5**(1.3-
1.7) 
1.8**(1.6-2.0) 
Injuries 2461(55) 2044(45) 3.0**(2.8-
3.3) 
3.2**(3.0-3.4) 
Overall NCDs 7563(53) 6757(47) 2.8**(2.7-
3.0) 
3.0**(2.9.-3.1) 
Communicable disease 3459(28) 8781(72) Referencea Reference 
Note: ^ weighted analysis; CI stands for Confidence Interval; OR stands for Odds Ratio; ** indicates 
p-value <0.001; Variables included in logit regression were age,  
sex, social group, education, income quintiles and type of health facility, ¥ >10% of annual household 
consumption expenditure; a reference category includes a list of communicable diseases as given in 
Box 1 
 
 
 
